MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$284,302K
EPS
-$1.97
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
267,852
312,779
188,138*
209,933
Acquired manufacturing rights
-
-
0*
-
General and administrative
34,925
33,071
32,639*
32,447
Total operating expenses
302,777
345,850
220,776
242,380
Loss from operations
-302,777
-345,850
-220,776*
-242,380
Interest income
25,755
26,610
29,220*
29,259
Other (expense) income
-7,280
-1,382
-5,967*
291
Total other income, net
18,475
25,228
23,253*
29,550
Net loss
-284,302
-320,622
-197,523
-212,830
Basic EPS
-1.97
-2.3
-1.452
-1.56
Diluted EPS
-1.97
-2.3
-1.452
-1.56
Basic Average Shares
144,494,106
139,506,680
136,038,260
136,196,512
Diluted Average Shares
144,494,106
139,506,680
136,038,260
136,196,512
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income
$25,755K
(-17.11%↓ Y/Y)
Net loss
-$284,302K
(-70.68%↓ Y/Y)
Total other income,
net
$18,475K
(-69.03%↓ Y/Y)
Other (expense)
income
-$7,280K
(-125.48%↓ Y/Y)
Loss from operations
-$302,777K
(-33.84%↓ Y/Y)
Total operating
expenses
$302,777K
(33.84%↑ Y/Y)
Research and development
$267,852K
(37.94%↑ Y/Y)
General and
administrative
$34,925K
(9.00%↑ Y/Y)
Buy us a coffee
Vaxcyte, Inc. (PCVX)
Vaxcyte, Inc. (PCVX)